lung cancer trial update The final patient has been enrolled in our phase 3 pivotal LUNAR trial evaluating the efficacy of Tumor Treating Fields together with immune checkpoint inhibitors or docetaxel for treatment of patients with advanced stage 4, non-small cell lung cancer following progression while on or after platinum-based therapy. LEARN MORE mechanism of action Tumor Treating Fields is a cancer therapy that uses electric fields to disrupt cancer cell division. join our team We count on our talented team members who are committed to our mission of striving to extend survival in some of the most aggressive forms of cancer. news and media See what we’ve been up to and access materials related to our company, our people and our therapy. PRESS RELEASES the story of Novocure We are a global oncology company striving to extend survival in some of the most aggressive forms of cancer. In 2000, our founder Professor Yoram Palti sought to leverage his expertise in biophysics to develop a new way to treat cancer that would destroy tumor cells while sparing healthy tissue and avoiding many of the life-altering side effects of existing cancer therapies. Novocure has grown into an international oncology company with more than 1,000 employees and operations in the U.S., Europe and Asia. With more than 20 years of research and many significant milestones, we believe we are only beginning. LEARN MORE we can leverage physics to fight cancer Tumor Treating Fields is a cancer therapy that uses electric fields to disrupt cancer cell division. OUR THERAPY explore our clinical pipeline Our research shows that Tumor Treating Fields have an antimitotic effect in more than 18 solid tumor types in culture and in eight in vivo tumor models. OUR PIPELINE we are dedicated to making a difference in cancer Patients remain at the heart of the work we do every day. Learn more about our patients, their families and the people working to deliver patient-forward therapies to treat cancer. PATIENT-FORWARD about us leadership corporate presentation esg our therapy our pipeline novocuretrial.com patient-forward news and media press releases press kits media gallery featured stories investor relations press releases corporate presentation events annual reports sec filings stock information corporate governance faq email alerts careers our locations current job listings corporate compliance california consumer privacy notice website privacy policy hipaa privacy notice terms and conditions site map novocure vulnerability disclosure process data privacy policy – novocure.com On this site, videos and images identified as Optune users, caregivers or healthcare professionals depict actual patients, caregivers and healthcare professionals. Patient images reflect the health status of the patients at the time each photo or video was taken. © 2021 Novocure GmbH – all rights reserved Cookie Policy This website intends to use cookies to improve the site and your experience. By continuing to browse the site you are agreeing to accept our use of cookies. If you require further information and/or do not wish to have cookies placed when using the site, review the Cookies section of our website privacy policy or visit www.allaboutcookies.org.